Biologic Drug Denied by Insurance? How to Fight Back

Biologic Drug Denied by Insurance? How to Fight Back

Biologic medications — Humira, Enbrel, Dupixent, Cosentyx, Rinvoq, Xeljanz, Otezla — are among the most effective treatments available for autoimmune and inflammatory conditions. They are also among the most expensive, running $20,000 to $80,000 per year. That cost is precisely why insurers routinely deny them. If your biologic was denied, you have strong grounds to appeal — and millions of patients successfully reverse these decisions every year.

What Are Biologics and Who Needs Them

Biologics are complex drugs derived from living cells that target specific components of the immune system. Unlike traditional small-molecule drugs, they are engineered to interrupt specific inflammatory pathways.

Common biologics and their indications include:

• Humira (adalimumab): rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis
• Enbrel (etanercept): rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis
• Dupixent (dupilumab): atopic dermatitis (eczema), asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis
• Cosentyx (secukinumab): plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis
• Rinvoq (upadacitinib): rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ankylosing spondylitis
• Xeljanz (tofacitinib): rheumatoid arthritis, psoriatic arthritis, ulcerative colitis
• Otezla (apremilast): plaque psoriasis, psoriatic arthritis

These are not experimental treatments. They are FDA-approved, guideline-supported standard of care for moderate-to-severe disease.

Why Insurers Deny Biologics

Denials almost always fall into one of these categories:

Step therapy requirements. The insurer demands you first try and fail older, cheaper drugs — typically methotrexate, sulfasalazine, hydroxychloroquine, or NSAIDs — before it will cover a biologic. This is the most common denial reason.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained. The prescriber submitted the prescription without obtaining advance approval. The fix is obtaining a retroactive authorization or restarting the process correctly.

Medical necessity dispute. The insurer's clinical reviewer decides your disease is not severe enough to warrant a biologic, often without examining you or reviewing your complete record.

Formulary exclusion. The specific biologic is not on the plan's covered drug list. Comparable biologics in the same class may be covered.

High cost triggers scrutiny. Insurers apply heightened review to any drug in this price range. That scrutiny generates more denials, not fewer appropriate ones.

Step Therapy Override Rights

Step therapy — "fail first" policies — is the single largest obstacle for biologic patients. But 40-plus states have enacted step therapy override statutes that give you and your physician the right to bypass step therapy requirements under specific circumstances.

Override is typically available when:

• You already tried and failed the required drugs (with documentation)
• The required drugs are contraindicated for you medically
• The required drugs would cause clinically significant adverse effects
• You were stable on the biologic before switching plans
• Your physician certifies the step therapy would delay needed care and risk permanent harm

Your physician plays a central role here. The physician must submit a step therapy override request citing the specific statutory grounds. Insurers are legally required to respond within defined timeframes — often 72 hours for urgent cases.

Building Your Prior Authorization Appeal

If the denial was a prior auth refusal rather than a step therapy issue, your appeal package should include:

Specialty society guidelines. The American College of Rheumatology (ACR), the American Academy of Dermatology (AAD), and the European League Against Rheumatism (EULAR) publish evidence-based treatment guidelines that explicitly recommend biologics after conventional therapy failure. Print and cite the specific guideline relevant to your condition.

Physician letter. Your prescribing physician should write a detailed letter documenting disease severity, prior treatment history, why conventional therapies failed or are contraindicated, and the specific clinical rationale for the biologic prescribed.

Peer-reviewed studies. Published clinical trial data supporting the biologic for your specific indication strengthens the medical necessity argument.

Insurer's Clinical Policy Bulletin (CPB). Request a copy of the insurer's own coverage criteria for the drug. Address each criterion point by point in your appeal. If you meet every criterion listed, the denial has no defensible basis.

External Independent Review: Complete Guide" class="auto-link">External Review: Your Most Powerful Option

If your internal appeal is denied, request an independent external review immediately. External reviewers — IROs) Explained" class="auto-link">Independent Review Organizations (IROs) — are not employed by the insurer and have no financial incentive to deny.

IROs overturn biologic denials at a remarkably high rate. The reason is simple: when an FDA-approved drug is supported by major specialty society guidelines and prescribed by a board-certified specialist, classifying it as "not medically necessary" is clinically indefensible. External reviewers consistently reach that conclusion.

Under the ACA, you have the right to external review for any denial of a covered service.

Documentation Checklist

• Copy of the denial letter (with specific denial reason and clinical criteria cited)
• Physician letter documenting disease severity and treatment rationale
• Lab results confirming diagnosis (CRP, ESR, RF, anti-CCP, PASI score, etc.)
• Records of prior treatments tried and failed (dates, doses, duration, outcomes)
• ACR, AAD, or EULAR guideline pages supporting biologic use
• Insurer's Clinical Policy Bulletin for the specific drug
• Step therapy override request (if applicable), citing state statute
• Pharmacy benefit information confirming drug tier and formulary status
• Any peer-reviewed studies supporting use in your specific indication

Fight Back With ClaimBack

ClaimBack analyzes your denial letter, identifies the strongest appeal arguments, and generates a physician-ready appeal package in minutes.

Start your free appeal analysis at ClaimBack

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs. External Insurance Appeal: Which Should You File?